1. Home
  2. Collaborate

Tags : Collaborate

AWS and Onica Collaborate with Teva to Support its Digihaler Portfolio

AWS and Onica Collaborate with Teva to Support its Digihaler

Tuba Khan October 22, 2020

Shots: The three companies collaborated to build & host Teva’s Digital Health Platform which is a cloud-based backend data system, supporting the company’s FDA-approved Digihaler portfolio that consists of built-in sensors and Bluetooth wireless technology which connects to a mobile app that tracks inhaler events and measures inspiratory flow when a patient inhales Onica supported […]Read More

Novartis and Siemens Collaborate to Develop Blood Tests for Multiple Sclerosis

Novartis and Siemens Collaborate to Develop Blood Tests for Multiple

Tuba Khan September 24, 2020

Shots: The companies enter in a master agreement to design, develop, and commercialize diagnostic tests for therapies Novartis’ therapeutic pipeline The collaboration will initially focus on the development of serum neurofilament light chain (NfL) immunoassay for patients with MS and other neurological diseases Siemens will leverage its expertise in the development of clinical diagnostic solutions […]Read More

Boehringer Ingelheim and Click Collaborate on Digital Therapy for Behaviour Modification in Schizophrenia

Boehringer Ingelheim and Click Collaborate on Digital Therapy for Behaviour

Tuba Khan September 14, 2020

Shots: Click to receive $500M as up front, funding for research and development activities, clinical, regulatory & commercial milestones along with royalties on sales of CT-155 globally, will lead research and development activities and support Boehringer Ingelheim in global commercialization activities The companies will join their expertise to develop the mobile application, CT-155, which combines […]Read More

Chugai and Takeda Collaborate to Evaluate the Combination Therapy for Multiple Tumor Types in Japan

Chugai and Takeda Collaborate to Evaluate the Combination Therapy for

Tuba Khan September 11, 2020

Shots: Following a joint clinical research agreement between Roche and Exelixis and in conjunction with certain rights granted in Japan, Chugai and Takeda will study Tecentriq (atezolizumab) and Cabometyx (cabozantinib) as a combination therapy in Japan The three global P- III CONTACT studies are ongoing to investigate the combination of atezolizumab and cabozantinib as a […]Read More

AbbVie and Harvard University Collaborate to Develop Novel Therapies Against Emergent Viral Diseases

AbbVie and Harvard University Collaborate to Develop Novel Therapies Against

Tuba Khan August 25, 2020

Shots: AbbVie and Harvard University enter a $30M research alliance to study & develop novel therapies against emergent viral infections with an initial focus on coronavirus and the viruses leading to hemorrhagic fever The focus of the collaboration is to integrate fundamental biology into the pre/clinical development of new therapies for viral diseases AbbVie will […]Read More

Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

Bayer and One Drop Collaborate to Develop Digital Therapies Across

Tuba Khan August 24, 2020

Shots: The two partners will jointly enhance the existing platform utilizing One Drop’s know-how and capabilities of the One Drop platform and will co-develop digital health therapies across multiple therapeutic areas                One Drop will receive $98M financing, development fees and commercial milestones while in exchange Bayer will receive royalties on sales. In the future, Bayer […]Read More

SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19 Vaccine

SK bioscience Collaborate with Novavax to Supply Antigen for COVID-19

Tuba Khan August 14, 2020

Shots: SK bioscience signs a development and supply agreement for Novavax’ NVX-CoV2373 to supply it globally including the COVAX facility. SK bioscience will manufacture the vaccine antigen component for use in the final drug product SK bioscience will utilize its cell culture and recombinant protein capability, will initiate the production of the NVX-CoV2373 antigen at […]Read More

Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in the US

Teva and Alvotech Collaborate to Commercialize Five Biosimilar Candidates in

Tuba Khan August 5, 2020

Shots: Alvotech will lead the development, registration, and supply of the biosimilars, while Teva will be exclusively commercializing the products in the US. Alvotech will receive upfront with subsequent milestone payments over the next several years The companies will share the profit from the commercialization of the biosimilars. The collaboration leverages Teva’s commercial presence and […]Read More

Copyright ©2020 PharmaShots | Powered by Octavus Consulting